Interview: Pierre Faraldo – COO, Biopas, Colombia
Chief Operating Officer of Biopas, Pierre Faraldo, depicts the explosive growth the company has been achieving in the past 15 years to become one of Colombia’s success stories, with the…
Address: Calle 20 A # 44 – 70 Bogotá D.C.,Colombia
Tel: (571) 368 0077
Genfar S.A., a Multi-Latin company; legitimately Colombian, was established in August 18, 1967. It counts upon a pharmaceutical complex which is considered to be one of the most thorough and modern facilities throughout Latin America, due to his OUTSTANDING HUMAN TALENT AND TECHNOLOGY in all of its production processes; having corporate headquarters in Bogota, Colombia, subsidiaries in Peru and Ecuador, and dealers throughout Central and South America.
Genfar S.A., the pharmaceutical market leader nation wise; for more than 38 years has been committed to the manufacturing and production of generic, over the count, and under prescription drugs for both Human and Animal Health Division; which demonstrate a DEVELOPMENTAL AND INNOVATIVE process which has made a remarkable distinction over the quality of our products from the very first day.
It has kept its commitment over time to verify and guaranty the quality of its products, outstanding service, and its purpose for delivering to human kind, that which is most precious; the means to preserve both health and life.
We are a transparent, ethical, dynamic, flexible, solidary, and benevolent company with a sense of environmental and social responsibility, dedicated to developing, manufacturing, and marketing drugs and products characterized by their quality, effectiveness, innovation, and economy, devoted to the national and international markets.
We rely on state entities; providers; advanced technology and great HUMAN RESOURCES, oriented towards excellence in the service and satisfaction of health necessities and/or well-being of our consumers, customers in general, and health professionals.
We are committed to the development of our contributors and their families; assuring our share holders the highest satisfaction and profitability.
OTC PRODUCT LINE
Acetaminophen
Calcium
Calcium + Vitamin D
Calprax®
Clotrimazole Topical Cream
Diclofenaco Emulsion – Gel
genfargrip
Ibuprofen
Iodine Povidone
Isoconazole
Ketoprofen Gel
Piroxicam gel
terbinafina
Vitamin C
MEDICAL PRESCRIPTION PRODUCTS
Aciclovir
Aciclovir cream
Aciclovir Ointment
Albendazole
Alendronate
Ambroxole
Amlodipine
Amoxicillin
Ampicillin
Atorvastatine
Azytromicine
Betamethasone
Betamethasone + clotrimazole + neomicine
Betamethasone injectable
Buspirone
Candesartan
Captoprile
Carbamazepine
Cefadroxil
cefalotina
Cefotaxime
Ceftazidime
Ceftriaxone
Cefuroxime
Celecoxib
Cephalexin
Cephazoline
Cephradine
Cetirizine
Ciprofloxacine
Clarithromycin
Clindamycin
Clotrimazole
Crotamiton
Diclofenac
Dicloxacillin
Diltiazem
Dinak
Enalapril
Erithromicin
Esomeprazol
Flubendazole
Fluconazole
Flunarizin
Fluoxetin
Furosemide
Fusidic Acid
Gemfibrozile
Genfargrip
Gentamicin
Ginkgo Biloba
Gleminex
Glucinex
Hydrochlorothiazide
Hydroxicine
Ibuprofen + Metocarbamole
Isosorbide Mononitrate
Ivermectin
ketoconazole
ketoconazole Cream
Ketoprofen
Ketorolac
Ketotifen
Lansoprazole
Levofloxacine
Lincomycin
Loratadine
Losartan
Lovastatin
Mebendazole
Metgluk
Metoclopramide
Metronidazole
Mometasone
Montelukast
Naproxene
Nifedipine
Norfloxacine
Omeprazole
Penicillin G Benzathine
Penicillin G Procaine
Penicillin G Procaine + Penicillin G Sodium
Penicillin G Sodium
Pentoxifylline
Piracetam
Piroxicam
Pravastatin
Propranolol
Pyrantel Pamoate
Ranitidine
Salbutamole
Secnidazole
Sertraline
Sibutramine
SIDELG
sildenafil
silimarine
Silver sulfadiazine
simvastatin
Sumatriptan
Tenoxicam
Teophylline Retard
Terbinafina
Tetracycline
Thiamine
Tinidazole
Tramadol
Trimebutine
Trimethoprim Sulfa
Trimethoprim Sulfa F
Tyclopidine
Valsartan
VALSARTÁN + HIDROCLOROTIAZIDA Genfar®
Verapamil
Vitamin B Complex
Xilbac
zolpidem
Zopiclone
Chief Operating Officer of Biopas, Pierre Faraldo, depicts the explosive growth the company has been achieving in the past 15 years to become one of Colombia’s success stories, with the…
Sunil Dhyani, general manager of IPCA in Colombia, a successful Indian firm continuously launching new molecules, shares his take on the company’s strategy decisions in Colombia, as well as wider…
Thomas Voigt, executive president of the German Chamber of Commerce in Colombia for seven years, discusses the gradual decentralisation of business in Colombia and the increasingly long-term commitment of German…
Francois Léger, recently appointed GM of Servier Colombia discusses his strategy to achieve the company’s ambitious growth plans to launch eight new products within the next three years. You have…
Jaime Calderon, CEO of IETS and with an extensive clinical background and deep understanding of the Colombian healthcare sector, shares IETS’ role in advancing the healthcare landscape while promoting superior…
Pfizer’s country manager and PEH Lead for Colombia & Venezuela, Diego Forero, shares his insights on the Colombian pharmaceutical market, his goals for Pfizer’s Colombian affiliate, and how Colombian operations…
Mariella Soto, QuintilesIMS’ country manager for Colombia, has been working in the pharmaceutical-related industry for over 25 years. She explains how her previous experience as a pharmaceutical executive is helping…
Latin American Regional Head of MSN Labs, one of the most promising generics companies globally, Raman Wattamwar, speaks about the strength of the newly-formed affiliate in Colombia. He highlights Colombia’s…
Cristhian Salamanca, executive director of the Colombia-India Chamber of Commerce and Industry discusses the ties between both countries, the important role of the chamber in attracting Indian companies to Colombia,…
J&J Medical Devices regional VP Mircea Cubillos discusses the long-term vision for J&J in Colombia and Latin America. Moreover, he speaks about the company’s strategy for emerging markets, the importance…
Executive president of ACEMI (La Asociación Colombiana de Empresas de Medicina Integral), Jaime Arias, discusses fostering the constructive participation of all actors in the Colombian healthcare sector and the challenges…
With over a decade as executive director of the Pharmaceutical Chamber of ANDI (The Colombian National Business Association), Rodrigo Arcila Gomez, shares his optimistic insights on the growth of the…
See our Cookie Privacy Policy Here
